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Research
corner

Efficacy and safety of ofatumumab compared to
teriflunomide in patients with relapsing multiple
sclerosis (ASCLEPIOS 1)
A Randomized, Double-Blind, Double-Dummy, ParallelGroup Study Comparing the Efficacy and Safety of
Ofatumumab Versus Teriflunomide in Patients With
Relapsing Multiple Sclerosis (MS)
• Clinical trials identifier: NCT02792218
• Local principal investigator: Akram Dastagir, MD
• Research coordinator: Carol Halliday, RN, BA
• Sponsor: Novartis Pharmaceuticals
• Phase: III

Breaking down barriers in brain cancer
With almost 20 years in the laboratory, senior research
scientist Santhi Konduri, PhD, is on the cusp of translating
her research into a clinical trial, providing a new
investigational option in the fight against brain cancer.
Since joining Aurora Research Institute in July 2013, Dr.
Konduri has focused on combining existing chemotherapy
drugs with drugs approved for other indications in an
attempt to increase survival and decrease toxic effects in
hard-to-treat cancers.

Applying these initial results, Dr. Konduri is testing
combinations on brain cancer, specifically glioblastoma
multiforme, a rapidly growing and aggressive brain tumor.
“Some of these patients are dying within six to nine months
of their diagnosis,” Dr. Konduri said. “It is too difficult for many
drugs to penetrate the brain, which makes them ineffective.”
Disulfiram can cross the blood-brain barrier. But it needs help.
Dr. Konduri found that disulfiram plus copper inhibited
tumor growth almost 90 percent. With the addition of
copper, less disulfiram is needed; high levels of disulfiram
may cause neurotoxicities, which destroy normal brain cells.
Taking the research further, Dr. Konduri added the
chemotherapy drug temozolomide, which is approved for
treatment of glioblastoma multiforme.
She is currently working with neuro-oncologist George
Bobustuc, MD, and other researchers at Aurora to
determine what types of patients may be eligible for a
clinical trial and most appropriate for this type of therapy.
Principal biostatistician, Maharaj Singh, PhD, is aiding with
statistical analysis.
Going forward, Dr. Konduri wants to use this type of
collaboration to continue to develop new combination
approaches to prevent or treat various tumor types. ■

Dr. Konduri and her team evaluated the FDA-approved
drug disulfiram as part of a combination therapy that
significantly decreased tumor cell growth in both pancreatic
and breast cancers.

Aurora St. Luke’s EEG lab accreditation
The Laboratory Accreditation Board of ABRET has
granted the EEG Laboratory at Aurora St. Luke’s
Medical Center a five-year accreditation. This award is
based on an evaluation of the technical quality of the
EEGs performed in this lab and on a review of specific
2

policies from the Policy and Procedure Manual. The
lab has been commended on their desire to promote
excellence and competency in the department, which
has had a positive influence. There are only 156
accredited labs in the country. ■
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We’re excited to welcome new providers to our team
Taylor Finseth, MD, believes in the
role of the physician as educator to
empower patients and their caregivers
to lead the best life possible. Dr. Finseth
provides management of movement
disorders, including Parkinson’s Disease,
tremor, dystonia, restless legs and deep
brain stimulation programming; he also
performs botulinum toxin (BOTOX)
injections for dystonia, chronic
migraine and other conditions. He encourages the use
of nonpharmacological treatments, such as exercise and
other complementary modalities.

Dr. Finseth earned his medical degree at The Ohio State
University College of Medicine in Columbus, and completed
both his residency in Neurology and fellowship in Movement
Disorders at the University of Colorado in Aurora. He is
Board-certified by the American Board of Psychiatry and
Neurology. In his free time, Dr. Finseth enjoys playing soccer,
live music and spending time outside.
Neurology and Movement Disorders
Aurora Health Care
2801 W. Kinnickinnic River Parkway, Suite 550
Milwaukee, WI 53215 • 414-385-8780

Aaron H. Bubolz, DO, is skilled in
procedures such as BOTOX, nerve
blocks, trigger point injections,
osteopathic medical therapy and EEGs.
He also provides treatment for ailments
such as headache, face pain, neck pain,
nerve pain/neuropathy, seizures, stroke,
multiple sclerosis, Parkinson’s disease,
tremors, ALS and myasthenia gravis. His

areas of interest include headache, epilepsy and stroke.
Dr. Bubolz received his medical degree from Des Moines
University, Iowa. He completed his residency in neurology
at the University of Kansas. He also completed a fellowship
in headache medicine at Mayo Clinic, Rochester, Minn.

Shawn Whitton, MD, is skilled in
providing video EEG, ambulatory EEG,
evoked potentials, WADA testing,
lumbar punctures, intraoperative/
extraoperative mapping and vagus
nerve stimulation. His areas of interest
include epilepsy/seizures and neurology.

Dr. Whitton received his medical degree from Ross
University School of Medicine, Portsmouth Dominica,
West Indies. He completed his residency in neurology at
the University of Missouri. Dr. Whitton also completed an
epilepsy fellowship at the University of Michigan.

Willson H. Luy Tan, MD, provides
general neurology care for issues such
as headache; movement disorders;
epilepsy; behavioral neurodegenerative
disorders, including Alzheimer’s disease
and other dementias; autoimmune
disorders, including multiple sclerosis;
cerebrovascular disorders, including
stroke; neuro-otology; neuromuscular
disorders; and sleep disorders.

interest include neurodegenerative disorders, Parkinson’s
disease, epilepsy and cerebrovascular disorders.

Dr. Luy Tan also provides electroencephalography (EEG),
electromyography (nerve conduction/EMG) lumbar
punctures, skin biopsy for peripheral neuropathy, and
therapeutic BOTOX injections (dystonias). His areas of

Neurology • Aurora BayCare Medical Center
2845 Greenbrier Road, Suite 140
Green Bay, WI 54311 • 920-288-8100

Neurology • Aurora BayCare Medical Center
2845 Greenbrier Road, Suite 140
Green Bay, WI 54311 • 920-288-8100

Board-certified in neurology, Dr. Luy Tan received his
medical degree from the University of the Philippines. He
completed a residency in neurology at the University of
Pittsburgh. ■
Neurology • Aurora Health Center
210 Wisconsin American Drive
Fond du Lac, WI 54937 • 920-907-7000
Neurology • Aurora Health Center
855 N. Westhaven Drive
Oshkosh, WI 54904 • 920-303-8700
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Raising awareness about MS
By Dr. Lea Rayman
Neurology
Aurora Health Care
(offices in Summit and Waukesha)
Eating breakfast … writing your grocery
list … walking to the car. Most of us
do these activities without a second
thought. But for a person with a
movement disorder, the easiest daily
living tasks can be challenging—or even dangerous. One
well-known neurological disorder that often results in
problem with movement is multiple sclerosis (MS).
MS is considered an immune-mediated disease in which
the body’s immune system mistakenly attacks myelin in
the central nervous system. In multiple sclerosis, damage
to the myelin, and to the nerve fibers themselves,
interferes with transmission of nerve signals between the
brain and spinal cord and other parts of the body.
MS is an unpredictable, often disabling disease. It affects
women more than men and most commonly begins
between the ages of 20 and 40.
Doctors aren’t sure of the cause of multiple sclerosis.
Most theories point to a virus, a genetic defect or a
combination of both. Some scientists believe the disease
is triggered by an unidentified environmental factor in a
person who is genetically predisposed to respond.

What are the symptoms of MS?
No two people have the exact same multiple sclerosis
symptoms, but there are certain signs that are
widespread, such as:
• fatigue
• numbness or tingling
• weakness
• walking problems
• vision problems
• dizziness

• perform other tests, including an MRI and spinal
fluid analysis
These evaluation techniques will help your doctor make
an accurate diagnosis. After receiving a diagnosis of MS,
a neurologist can work with you to determine the best
way to slow the destruction of your nerves’ protective
coating (myelin).

MS is an unpredictable,
often disabling disease. It
affects women more than
men and most commonly
begins between the ages
of 20 and 40.
It’s important to treat MS early on. The right MS
treatment can significantly reduce symptoms and
prevent them from becoming disabling. Multiple
sclerosis treatment options include:
• injectable therapies
• oral pills
• IV or oral steroids
• anti-cancer drugs that suppress the immune system
• plasma exchange therapy (plasmapheresis)
A comprehensive treatment plan for MS should include:
• education on managing MS symptoms
• recommended lifestyle modifications to 		
enhance health
• information on health and community resources

• bladder or bowel problems

• guidance on nutrition, exercise planning, 		
physical therapy

• emotional changes

• counseling for emotional issues

• balance problems
If you have multiple sclerosis symptoms, your doctor (a
neurologist) will thoroughly evaluate you and may order a
series of tests in order to make a diagnosis. He or she will:
• work to understand your full medical history
• conduct a neurologic exam
4

If you or a loved one is dealing with a diagnosis of MS,
please seek medical care that treats the whole person—
including the person’s spiritual, physical and emotional
needs. There are many support groups and patient
education resources available for patients who have MS
and their families. ■
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Couple’s love transcends early-onset dementia
Milwaukee Journal Sentinel
By Crocker Stephenson
Mike Grassel loves Julie Grassel and Julie loves Mike.
That’s the way it is and that’s the way it has been for
more than 30 years. And someday, Julie says, when
they die and join each other in heaven, she will remind
Mike of all that has happened.
Mike remembers some of it, though he remember less
than he once did, and in the years to come he will
remember less and less. As for now, he remembers
meeting Julie on their first day of college, in a
psychology class at University of Wisconsin-Milwaukee.
As for now, he remembers how it quickly became
clear to them both that they would live out their lives
together. As for now, he can remember that in their
sophomore year, as his mother was driving him to work
on Interstate 94, a wheel came loose from an oncoming
car, smashed through the windshield of their car and,
without harming his mother, hit him in the head. When
he regained consciousness a week later, he didn’t know
who Julie was.
Julie stayed at Mike’s side as he re-entered his life.
Relearned to walk. Relearned to talk. Relearned the
simplest things. People asked Julie why. Even Mike
asked her why. He was changed. The man she fell in
love with was now a different man. She could go on
with her life. Without him. No one would blame her.
Why not go on without him?
“I didn’t even understand the question,” Julie says. “I
had made a commitment. Nothing changed for me.”
In time, Mike returned to school and got his degree.
He and Julie married, built careers, had two kids—
Stephanie and Nick—and settled down in Brookfield.
And then, about seven years ago, Mike began to forget.
Connections in his brain came apart. Well-worn neural
pathways came to confusing dead ends. Where once
there was something, there was now a gap. Mike was
just 43 years old, and his doctor thought he might have
early-onset Alzheimer’s disease. The diagnosis was
modified to progressive dementia, the result of his brain
injury. But Mike’s prognosis remained much the same as
it had been for Alzheimer’s. He will forget.
Early-onset Alzheimer’s affects people younger than
65. The Alzheimer’s Association estimates that about
5 percent of the more than 5 million Americans with
Alzheimer’s have an early onset, sometimes called
younger onset, form of the disease.

Early-onset Alzheimer’s
affects people younger
than 65.
Many people who sustain a severe head injury never
develop Alzheimer’s disease or dementia. More
research is needed to understand the link. Mike and
Julie have adjusted their lives so that Mike remains
social and connected, and they are very active in the
array of programs offered through the Southeastern
Wisconsin Chapter of the Alzheimer’s Association.
And to Mike’s surprise, he has found a new passion: art.
On a recent evening, Julie drops Mike off at the Donna
Lexa Art Center, located in a building behind the First
Baptist Church in Waukesha. Donna Lexa offers art
classes to students with special needs, like cerebral
palsy, schizophrenia, brain injury, Down syndrome,
stroke, autism and Alzheimer’s. The classroom smells
like glue and markers. A riot of work hangs on all the
walls and covers virtually every horizontal surface. Dolls
hang in a set of windows that run the length of a wall
and look out on a park across the street.
A dozen students, and about half as many volunteers
and staff, sit around a table in the center of the room.
The mother of one the students, Mary Green, has died.
In grief, Mary has drawn a portrait of her mother on a
sheet of cardboard and cut it out. The cutout sits on the
chair beside her. The room is already a blur of activity, but
everything kicks up a notch when Mike comes in, wearing
a T-shirt he’s dyed with Packers green and gold. He goes
around the room distributing hugs and compliments.
“That’s really cool,” he says. “Oh that’s awesome. Wow,
look at that!” The windows darken. Wind pushes against
them and there’s a lashing of rain. The classroom is
warm and bright and loud. Mike puts music on his
phone. He gets people to sing with him. He gets
them to dance. Mike is working—more or less—on a
landscape collage. By the time Julie comes to pick him
up, he’s only added a few things. The dominant feature
of Mike’s landscape is a rainbow. Rainbows appear in a
lot of his work. They stand for hope, he says.
That’s what he’s about, he says. Even now. Especially
now. Hope.
“I almost died,” Mike says. “I was gone and then I was
there.” “It’s all bonus,” he says, and then he says it
again. “It’s all bonus.” ■
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Burlington hospital volunteer saves herself
The Journal Times Racine
By Mark Feldmann
Listening is a skill. Sometimes it’s a lifesaver.
Just ask Burlington resident Dorothy Hakala, who
worked as a guidance counselor in the Burlington
Area School District for 30 years. It was her open ears
and alert mind that helped her avoid a massive—and
potentially fatal—stroke earlier this summer.
“It hit me a few days after it was all over that this was
something that could have been really bad,” said the
69-year-old. “It could have turned out very different.”
After retiring in 2005, Hakala started to volunteer at
Aurora Memorial Hospital of Burlington. She chairs the
scholarship committee, helps families in the day surgery
area, and participates in several healthy kids initiatives.
She quickly became president of the volunteers at the
hospital. As part of their service, Hakala and the other 160
volunteers review stroke education each April and remind
themselves how to discern the symptoms of a stroke, said
Kathy Galstad, Aurora’s manager of ancillary services.
“Because we are a primary stroke center, we need to
have our volunteers have a refresher on stroke signs
every year,” Galstad said. “We want to get that message
out.” Hakala paid close attention in the inservice, even
though she was hearing the presentation for the eighth
time. Never in her wildest dreams did she think the
person she would save using her stroke knowledge
would be herself.

Sensing the symptoms
About two months after taking the stroke course,
Hakala and her husband, John, were returning from
Galena, Ill., where they were celebrating their 48th
wedding anniversary. Hakala noticed her left arm went
6

completely numb for almost 10 seconds. “Looking back,
I remembered feeling some tingling sensation, but I
figured it was probably nothing,” she said. “But this time
it was so heavy and limp.”
Recalling her stroke training, Hakala surmised she
might be having a stroke. The couple drove directly to
the Midwest Medical Center in Galena, where she was
assessed in the emergency room and told she was right:
She had experienced a transient ischemic attack (TIA),
where blood flow to part of the brain is blocked or
reduced by a clot.
The emergency room physician in Galena stabilized
Dorothy and sent her home, but told her she should
see her primary care physician immediately upon
her return for more tests. She did the next day. She
underwent several tests during the next five days.
Doctors discovered that one of her arteries was almost
95 percent blocked. “There was only a trickle of blood
flowing,” she said. “The doctors told me that I could have
had a massive stroke at any time.”

Surgery and recovery
On July 1, she underwent surgery to clear the blockage.
Lief Erickson, a surgeon who specializes in vascular
and laparoscopic surgery, performed the four-hour
operation. She went home the next day, and three weeks
later, returned to the hospital to volunteer.
“I feel very lucky and very blessed,” Hakala said. “I have a
strong faith and I believe God still has work for me to do.”
For Hakala, finding out she had severe artery blockage
was a shock. “I had no idea,” she said. “I think I’m a pretty
healthy person and I stay active. But so many people
ignore symptoms. Your body will send you signals. When
it does, it’s usually trying to tell you something.” ■
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B.E.F.A.S.T. is an easy way to remember the sudden
signs of stroke

Balance

B

Do you have sudden loss of
balance or coordination?

Eyes

E

Is your vision blurred? Do you
have double vision or sudden
trouble seeing out of one or
both eyes?

Face

F

Can you smile? Does one side
of the face sag or droop?

Arms

A

Can you raise both arms?
Or does one arm
drift downward?

Speech

S

Is your speech slurred or
strange-sounding? Can you
repeat a single sentence?

T

Sudden onset of a terrible
headache or “the worst
headache of your life.” Every
minute counts! Call 9-1-1
immediately if you
are experiencing any of
these symptoms.

Terrible
Headache
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Initial experience with a robotically operated video optical
telescopic-microscope in cranial neurosurgery: feasibility,
safety, and clinical applications
Lior Gonen, MD; Srikant S. Chakravarthi, MD;
Alejandro Monroy-Sosa, MD; Juanita M. Celix,
MD, MPH; Nathaniel Kojis, Maharaj Singh, PhD;
Jonathan Jennings, MD; Melanie B. Fukui, MD;
Richard A. Rovin, MD’ and Amin B. Kassam, MD
Aurora Neuroscience Innovation Institute, 		
Aurora St. Luke’s Medical Center, Milwaukee
Technological innovation is an important driver in the
development of new medical procedures and surgical
techniques. The concept of robotics and integration
especially has been a recent topic of interest in the
surgical realm, with an effort to create more efficient
operative platforms (6, 13).
The development of surgical robotic devices is founded
on the principle of a human-machine interface, which
is integral to the definition of a robot. By programming
an integrated computer unit, this platform can be
referred to as human-computer-machine interface. We
consider surgical robotics in the following three broad
classifications:
• Detectors are robotic devices that enhance optical
visualization (i.e., equivalent to the human eye)
• Effectors are robotic devices that enhance dexterity,
maneuverability and scale motion (i.e., equivalent to
the human hand)
• Integrative/intelligent robotic devices capture
information through iterative processes and are
able to predict and define a series of steps based
on this “learned information” (i.e., equivalent to the
human brain)

Explicitly, detector, effector and integrative systems may
also be referred to as “robotic eyes,” “robotic hands,”
and the “robotic mind,” respectively.
Historically, interest in surgical robotics has been
primarily focused on effector robots for the purposes
of enhanced dexterity and superior micromanipulation.
Such devices have been recently introduced into other
surgical subspecialties (7, 10, 11, 21). However, as noted
by Peter Jannetta in a personal communication, one
of the first neurosurgeons to document and integrate
the microscope into neurosurgery in 1968, “… the hand
cannot perform if the eye cannot see …” (25). This may
have been why the development of effector robots in
neurosurgery has been profoundly limited; specifically,
inadequate visualization has been a rate-limiting step.
In other words, the enhanced maneuverability that
might be achieved by effector robotic devices would
only become valuable once the visualization scale
demands it. Therefore, the first step toward a meaningful
integration of robotics into neurosurgery should focus
on the detector system, followed by the effector.
Enhanced visualization represents the very essence of
microscopy (from the Greek mikros, “small,” and skopein,
“to look”). This can occur with binocular visualization
with conventional stereoscopic microscopes or other
alternative systems (18, 28). In this report, we present
the application of a novel detector system, namely,
the robotically operated video optical telescopicmicroscope (ROVOT-m; BrightMatter Servo System,
Synaptive Medical). Specifically, within this optical
chain, three individual components were designed in an
attempt to leverage the synergistic performance of the
overall chain:

DISTRIBUTION OF THE FIRST 200 PATIENTS REGARDING THE COMPLEXITY OF THE CASE

73
44

40

23
Complexity I
8

Complexity II

Complexity III

Complexity IV

7
Complexity V

13
Complexity VI

Edition 3 • September 2017

The operating room setup for the ROVOT-m. As shown, the 5 optical chain components include the optical payload (1), light source (2), camera
(3), holder (4), and display monitor (5). In this specific case, the setup was designed for a right-sided lesion. The general setup principles
are applied, and include the following: 1) The position of both the robotic arm and its base depends on the location of the pathology and the
resultant patient positions. In our experience, the robotic arm is typically positioned on the ipsilateral side of the lesion, with its base placed at
the patient’s hip level. 2) All joint angles are initially placed at 90° to allow for maximum unencumbered movement without creating singularity
(i.e., locking the joints). 3) The operating room setup must provide the surgeon and assistants with an unobstructed view of the monitors that
display the surgical view. We use at least 2 high-definition display monitors that, as a default, are positioned on the opposite side of the robotic
arm unit: one monitor directly in front of the surgeon and the other at a slight angle to allow for “stereoscopic” input with optics and navigation.
4) The image navigation guide system is positioned on the contralateral side of the robotic arm to allow for visualization.

• The payload: telescopicmicroscope (BrightMatter
Vision). This is an exoscope, distinct from existing
standalone exoscopes, in that it is purpose-built for
the ROVOT-m.
• The navigation system: (BrightMatter Guide). This
system creates an automated human-machine
interface, tracking the relative position of the
payload and a series of instruments within the
operative field.
• The positioning system: automated holding robotic
arm (BrightMatter Drive). This system uses the
computer-interfaced global positioning system to
automatically and robotically position the payload.
As a feasibility-only study, there are three objectives of
this report: to describe an initial experience in cranial
neurosurgery with the ROVOT-m, to assess the feasibility
and safety of this system in cranial applications, and
to describe the incremental experience needed to
overcome the associated learning curve.

Objective
The move toward better, more effective optical
visualization in the field of neurosurgery has been a
focus of technological innovation. In this study, the
authors’ objectives are to describe the feasibility and
safety of a new robotic optical platform, namely, the
robotically operated video optical telescopic-microscope
(ROVOT-m), in cranial microsurgical applications.

Methods
A prospective database comprising patients who
underwent a cranial procedure between April 2015
and September 2016 was queried, and the first 200
patients who met the inclusion criteria were selected as
the cohort for a retrospective chart review. Only adults
who underwent microsurgical procedures in which the
ROVOT-m was used were considered for the study.
Preoperative, intraoperative and postoperative data were
retrieved from electronic medical records. The authors
address the feasibility and safety of the ROVOT-m by
studying various intraoperative variables and reporting
perioperative morbidity and mortality, respectively.
To assess the learning curve, cranial procedures were
categorized into six progressively increasing complexity
groups. The main categories of pathology were I)
intracerebral hemorrhages (ICHs); II) intraaxial tumors
involving noneloquent regions or noncomplex extraaxial
tumors; III) intraaxial tumors involving eloquent regions;
IV) skull base pathologies; V) intraventricular lesions; and
VI) cerebrovascular lesions. In addition, the entire cohort
was evenly divided into early and late cohorts.

Results
The patient cohort comprised 104 female (52 percent)
and 96 male (48 percent) patients with a mean age
of 56.7 years. The most common pathological entities
encountered were neoplastic lesions (153, 76.5 percent),
followed by ICH (20, 10 percent). The distribution of
cases by complexity categories was 11.5 percent, 36.5
percent, 22 percent, 20 percent, 3.5 percent, and 6.5
(continued on page 10)
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Initial experience with a robotically operated video optical
telescopic-microscope in cranial neurosurgery: feasibility,
safety, and clinical applications (continued)
(continued from page 9)

Resection of a right parietal glioblastoma (Category II; corresponds to Video 2). A: Preoperative axial Gdenhanced T1-weighted MR image showing a right parietal glioblastoma with vasogenic edema. B: Intraoperative
photographs showing the trajectory of the port (B), which was designed preoperatively to avoid violating neural
tracts in the vicinity of the lesion, and the portal view.

percent for Categories I, II, II, IV, V and VI, respectively.
In all 200 cases, the surgical goal was achieved
without the need for intraoperative conversion. Overall,
the authors encountered three (1.5 percent) major
neurological morbidities and six (3 percent) 30-day
mortalities. Four of the six deaths were in the ICH group,
resulting in a 1 percent mortality rate for the remainder
of the cohort when excluding these patients. None of
the intraoperative complications were considered to
be attributable to the visualization provided by the
ROVOT-m. When comparing the early and late cohorts,
the authors noticed an increase in the proportion of
higher-complexity surgeries (categories IV–VI), from
23 percent in the early cohort to 37 percent in the late
cohort (p = 0.030). In addition, a significant reduction in
operating room setup time was demonstrated (p < 0.01).

Conclusions
The feasibility and safety of the ROVOT-m was
demonstrated in a wide range of cranial microsurgical
applications. The authors report a gradual increase in
case complexity over time, representing an incremental
acquisition of experience with this technology. New
adopters of the robot system should anticipate a
learning curve of both setup and execution phases.
Further prospective studies are required to address the
efficacy of ROVOT-m. This system may play a role in
10

neurosurgery as an integrated platform that is applicable
to a variety of cranial procedures.
Full Article: https://thejns.org/doi/
abs/10.3171/2017.3.FOCUS1712
©AANS, 2017 Neurosurg Focus Volume 42 • May 2017

Acknowledgements
We would like to thank Stryker Medical, Synaptive
Medical, Nico Corporation, and Karl Storz Corporation
for their support in the Aurora Neuroscience Institute
Neuroanatomical laboratory.

References

1. Blake R, Wilson H: Binocular vision. Vision Res 51:754–770, 2011
2. Brown LE, Marlin MC, Morrow S: On the contributions of vision
and proprioception to the representation of hand-near targets. J
Neurophysiol 113:409–419, 2015
3. Chang EF, Clark A, Smith JS, Polley MY, Chang SM, Barbaro
NM, et al: Functional mapping-guided resection of low-grade
gliomas in eloquent areas of the brain: improvement of long-term
survival. Clinical article. J Neurosurg 114:566–573, 2011
4. Cikla U, Swanson KI, Tumturk A, Keser N, Uluc K, Cohen-Gadol
A, et al: Microsurgical resection of tumors of the lateral and third
ventricles: operative corridors for difficult to reach lesions. J
Neurooncol 130:331–340, 2016

Edition 3 • September 2017
5. Cuschieri A: Visual displays and visual perception in minimal
access surgery. Semin Laparosc Surg 2:209–214, 1995
6. Doulgeris JJ, Gonzalez-Blohm SA, Filis AK, Shea TM, Aghayev
K, Vrionis FD: Robotics in neurosurgery: evolution, current
challenges, and compromises. Cancer Contr 22:352–359, 2015
7. Duran C, Kashef E, El-Sayed HF, Bismuth J: Robotic aortic
surgery. Methodist DeBakey Cardiovasc J 7:32–34, 2011
8. Eliyas JK, Glynn R, Kulwin CG, Rovin R, Young R, Alzate J, et
al: Minimally invasive transsulcal resection of intraventricular
and periventricular lesions through a tubular retractor system:
multicentric experience and results. World Neurosurg 90:556–
564, 2016
9. Fadul C, Wood J, Thaler H, Galicich J, Patterson RH Jr, Posner
JB: Morbidity and mortality of craniotomy for excision of
supratentorial gliomas. Neurology 38:1374–1379, 1988
10. Guru KA, Hussain A, Chandrasekhar R, Piacente P, Hussain A,
Chandrasekhar R, et al: Current status of robot-assisted surgery
in urology: a multi-national survey of 297 urologic surgeons. Can
J Urol 16:4736–4741, 2009
11. Hernandez JD, Bann SD, Munz Y, Moorthy K, Datta V, Martin S,
et al: Qualitative and quantitative analysis of the learning curve
of a simulated surgical task on the da Vinci system. Surg Endosc
18:372–378, 2004
12. Hofmeister J, Frank TG, Cuschieri A, Wade NJ: Perceptual
aspects of two-dimensional and stereoscopic display techniques
in endoscopic surgery: review and current problems. Semin
Laparosc Surg 8:12–24, 2001
13. Iavazzo C, Gkegke XE, Iavazzo PE, Gkegkes ID: Evolution of
robots throughout history from Hephaestus to Da Vinci Robot.
Acta Med Hist Adriat 12:247–258, 2014
14. Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL:
Expanded endonasal approach: the rostrocaudal axis. Part I.
Crista galli to the sella turcica. Neurosurg Focus 19(1):E3, 2005
15. Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL:
Expanded endonasal approach: the rostrocaudal axis. Part II.
Posterior clinoids to the foramen magnum. Neurosurg Focus
19(1):E4, 2005
16. Kassam AB, Prevedello DM, Carrau RL, Snyderman CH,
Thomas A, Gardner P, et al: Endoscopic endonasal skull base
surgery: analysis of complications in the authors’ initial 800
patients. J Neurosurg 114:1544–1568, 2011
17. Kaul S, Shah NL, Menon M: Learning curve using robotic
surgery. Curr Urol Rep 7:125–129, 2006
18. Kriss TC, Kriss VM: History of the operating microscope: from
magnifying glass to microneurosurgery. Neurosurgery 42:899–
908, 1998
19. Kumar A, Brown R, Dhar R, Sampson T, Derdeyn CP, Moran CJ,
et al: Early vs. delayed cerebral infarction after aneurysm repair
after subarachnoid hemorrhage. Neurosurgery 73:617–623, 2013

22. Mamelak AN, Danielpour M, Black KL, Hagike M, Berci G: A
high-definition exoscope system for neurosurgery and other
microsurgical disciplines: preliminary report. Surg Innov 15:38–46,
2008
23. Mamelak AN, Nobuto T, Berci G: Initial clinical experience
with a high-definition exoscope system for microneurosurgery.
Neurosurgery 67:476–483, 2010
24. Maniar HS, Council ML, Prasad SM, Prasad SM, Chu C,
Damiano RJ Jr: Comparison of skill training with robotic systems
and traditional endoscopy: implications on training and adoption.
J Surg Res 125:23–29, 2005
25. Rand RW, Jannetta PJ: Microneurosurgery: application of
the binocular surgical microscope in brain tumors, intracranial
aneurysms, spinal cord disease, and nerve reconstruction. Clin
Neurosurg 15:319–342, 1968
26. Sade B, Mohr G, Dufour JJ: Vascular complications of
vestibular schwannoma surgery: a comparison of the suboccipital
retrosigmoid and translabyrinthine approaches. J Neurosurg
105:200–204, 2006
27. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi
WM, et al: Neurosurgical outcomes in a modern series of 400
craniotomies for treatment of parenchymal tumors. Neurosurgery
42:1044–1056, 1998
28. Uluç K, Kujoth GC, Başkaya MK: Operating microscopes: past,
present, and future. Neurosurg Focus 27(3):E4, 2009
29. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra
A, Klijn CJ: Incidence, case fatality, and functional outcome of
intracerebral haemorrhage over time, according to age, sex, and
ethnic origin: a systematic review and meta-analysis. Lancet
Neurol 9:167–176, 2010
30. Zada G, Liu C, Apuzzo ML: “Through the looking glass”:
optical physics, issues, and the evolution of neuroendoscopy.
World Neurosurg 77:92–102, 2012
31. Zahuranec DB, Lisabeth LD, Sánchez BN, Smith MA, Brown
DL, Garcia NM, et al: Intracerebral hemorrhage mortality is
not changing despite declining incidence. Neurology 82:2180–
2186, 2014

Author Contributions

Conception and design: Kassam, Gonen, Chakravarthi
Acquisition of data: Gonen, Chakravarthi
Analysis and interpretation of data: Kassam, Gonen, Chakravarthi
Drafting the article: Gonen, Chakravarthi
Critically revising the article: Kassam, Gonen, Chakravarthi
Reviewed submitted version of manuscript: all authors
Approved the final version of the manuscript on behalf of all
authors: Kassam
Statistical analysis: Gonen, Chakravarthi
Administrative/technical/material support: Kassam
Study supervision: Kassam, Gonen, Chakravarthi ■

20. Labib MA, Shah M, Kassam AB, Young R, Zucker L, Maioriello
A, et al: The safety and feasibility of image-guided brainpathmediated transsulcul hematoma evacuation: a multicenter study.
Neurosurgery 80:515–524, 2017
21. Lin JC: The role of robotic surgical system in the management
of vascular disease. Ann Vasc Surg 27:976–983, 2013

11

Neuroscience Service Line 3000 W. Montana Street | Milwaukee, WI 53215

aurora.org/neuro

x88102b (09/17) ©AHC

